Understanding how proteins change their function in response to signals

Mapping and Exploiting the Internal Wiring of Structurally Dynamic Phosphatases

NIH-funded research Advanced Science Research Center · NIH-11011728

This study is looking at how certain proteins in our bodies change their behavior when they receive signals, which could help scientists create new medications for diseases like Alzheimer's that might work better for patients.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionAdvanced Science Research Center NIH-funded
Lab location1 site (New York, United States)
Project IDNIH-11011728 on NIH RePORTER

What this research studies

This research investigates the mechanisms by which proteins, specifically Protein Tyrosine Phosphatases (PTPs), alter their functions in response to cellular signals through a process called allostery. By employing advanced experimental techniques like X-ray crystallography and computational algorithms, the researchers aim to uncover the differences in how related proteins respond to signals. This understanding could lead to the development of new small-molecule drugs that target specific proteins involved in diseases such as Alzheimer's. Patients may benefit from insights gained into how these proteins can be modulated to improve treatment outcomes.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or related conditions that involve Protein Tyrosine Phosphatases.

Not a fit: Patients with conditions unrelated to Protein Tyrosine Phosphatases or those not diagnosed with Alzheimer's disease may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for treating conditions like Alzheimer's disease by targeting specific proteins involved in the disease process.

How similar studies have performed: Previous research has shown promise in understanding allosteric mechanisms in proteins, suggesting that this approach could yield significant insights.

Where this research is happening

New York, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.